Advertisement

Topics

FDA approves first treatment for certain types of poor-prognosis AML

07:35 EDT 4 Aug 2017 | thePharmaLetter

The US Food and Drug Administration has approved Vyxeos (daunorubicin and cytarabine) liposome for injection…

Original Article: FDA approves first treatment for certain types of poor-prognosis AML

NEXT ARTICLE

More From BioPortfolio on "FDA approves first treatment for certain types of poor-prognosis AML"

Quick Search
Advertisement